Engene Holdings Inc (ENGN)

$9

-1

(-10%)

Market is closed - opens 7 PM, 17 Jun 2024

Performance

  • $8.10
    $10.10
    $9.00
    downward going graph

    10.0%

    Downside

    Day's Volatility :19.8%

    Upside

    10.89%

    downward going graph
  • $6.69
    $43.00
    $9.00
    downward going graph

    25.67%

    Downside

    52 Weeks Volatility :84.44%

    Upside

    79.07%

    downward going graph

Returns

PeriodEngene Holdings IncIndex (Russel 2000)
3 Months
-46.59%
0.0%
6 Months
21.79%
0.0%
1 Year
-55.0%
0.0%
3 Years
-55.0%
-23.8%

Highlights

Market Capitalization
396.9M
Wall Street Target Price
34.4
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-29.38%
Return On Equity TTM
-330.6%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-32.0M
Diluted Eps TTM
0.0
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.27
EPS Estimate Next Year
-1.43
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Engene Holdings Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 282.22%

Current $9.00
Target $34.40

Technicals Summary

Sell

Neutral

Buy

Engene Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Engene Holdings Inc
Engene Holdings Inc
-33.92%
21.79%
-55.0%
-55.0%
-55.0%
Moderna, Inc.
Moderna, Inc.
8.5%
62.81%
7.73%
-30.54%
787.95%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
5.96%
20.65%
32.37%
96.5%
233.31%
Novo Nordisk A/s
Novo Nordisk A/s
5.82%
46.76%
75.35%
237.0%
458.71%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
9.88%
17.06%
37.71%
154.39%
176.63%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Engene Holdings Inc
Engene Holdings Inc
NA
NA
NA
-1.27
-3.31
-0.29
NA
NA
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-6.71
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
30.32
30.32
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
49.73
49.73
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.07
31.07
0.53
17.09
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Engene Holdings Inc
Engene Holdings Inc
Buy
$396.9M
-55.0%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$55.7B
787.95%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$113.1B
233.31%
30.32
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$634.9B
458.71%
49.73
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$123.6B
176.63%
31.07
39.46%

Company Information

Organization
Engene Holdings Inc
Employees
31
CEO
Mr. Jason D. Hanson Esq., J.D.
Industry
Miscellaneous

FAQs